LA
MEDP icon

LM Advisors’s Medpace MEDP Stock Holding History

LM Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20
Closed -$6.19K – 522
2023
Q4 		$6.19K Buy
+20
New +$5.4K ﹤0.01% 575

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

LM Advisors's MEDP Position: Q1 2024 in Review

LM Advisors sold out of Medpace (MEDP) in Q1 2024, closing a stake of 20 shares — an estimated $6.19K sold.

LM Advisors first reported a position in MEDP in Q4 2023 and held it in 1 quarter. The position peaked at $6.19K in Q4 2023. 596 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • LM Advisors reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • LM Advisors sold 20 Medpace shares in Q1 2024, an estimated $6.19K.
  • LM Advisors first reported a position in Medpace in Q4 2023 and held it in 1 quarter.
  • LM Advisors's Medpace position peaked at $6.19K in Q4 2023.
  • 596 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on LM Advisors's 13F filing for Q1 2024, filed 15 May 2024.